Can Nutrafol cause hair loss? It is a question increasingly asked by UK consumers drawn to this popular botanical hair supplement. Nutrafol is a US-based dietary supplement containing ingredients such as biotin, ashwagandha, saw palmetto, and marine collagen, marketed to address hair thinning. In the UK, it is classified as a food supplement rather than a licensed medicine and is not regulated by the MHRA for safety or efficacy. This article examines the evidence around Nutrafol's side effects, who should use it with caution, when to seek medical advice, and what evidence-based alternatives are available through UK healthcare.
Summary: There is no established clinical evidence that Nutrafol directly causes hair loss, though some users report early shedding, and the supplement carries several safety considerations worth reviewing before use.
- Nutrafol is a food supplement, not a licensed medicine, and is not assessed by the MHRA for safety or efficacy before sale in the UK.
- High-dose biotin in Nutrafol can interfere with immunoassay-based blood tests, including thyroid function and cardiac troponin assays — inform your GP before any blood tests.
- Ashwagandha, a key Nutrafol ingredient, has been linked in case reports to rare but serious liver injury (hepatotoxicity); seek urgent medical attention if jaundice or dark urine develops.
- Pregnant or breastfeeding women, those with hormone-sensitive conditions, and people on prescription medications such as warfarin or thyroid drugs should consult a GP before use.
- Evidence-based UK treatments for hair loss include topical or oral minoxidil and finasteride (for men), both of which have regulatory oversight and established clinical trial data.
- Any suspected adverse reactions to Nutrafol should be reported via the MHRA Yellow Card scheme to support UK supplement safety monitoring.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
What Is Nutrafol and How Is It Used for Hair Health?
Nutrafol is a botanical hair supplement classified as a food supplement in the UK, meaning it is not assessed by the MHRA for safety or efficacy and is not endorsed by NHS hair loss guidance.
Not sure if this is normal? Chat with one of our pharmacists →
Nutrafol is a US-based dietary supplement brand marketed primarily for hair thinning and hair loss. Its products are formulated with a blend of botanical ingredients, vitamins, and minerals, including biotin, ashwagandha (Withania somnifera), saw palmetto, marine collagen, and various antioxidants. The brand positions its supplements as targeting multiple root causes of hair thinning, such as hormonal imbalances, stress, nutritional deficiencies, and inflammation.
It is important to note that Nutrafol is classified as a food supplement rather than a licensed medicine in the UK. Unlike prescription or over-the-counter medicines, it is not assessed by the Medicines and Healthcare products Regulatory Agency (MHRA) for safety or efficacy before sale. Food supplements sold in the UK are instead governed by UK food law, overseen by the Food Standards Agency (FSA) and local Trading Standards authorities. This means Nutrafol has not undergone the rigorous clinical trial process required for pharmaceutical approval.
Some small, largely industry-funded studies have suggested improvements in certain hair growth metrics, but independent, large-scale clinical evidence remains limited. The NHS hair loss guidance does not endorse hair supplements as a treatment for conditions such as androgenetic alopecia or telogen effluvium, and Nutrafol is not available through the NHS.
Nutrafol is typically taken as a daily oral capsule, with the brand recommending consistent use over several months before results may become apparent. It can be purchased online in the UK. As with any supplement, understanding its ingredients, potential interactions, and suitability for your individual health profile is essential before starting use.
| Concern / Reaction | Ingredient(s) Involved | Evidence Level | Severity | Recommended Action |
|---|---|---|---|---|
| Increased hair shedding (early use) | Multiple / mechanism unclear | Anecdotal only; not clinically established | Uncertain | Do not assume normal; seek medical review if shedding persists or worsens |
| Gastrointestinal discomfort (nausea, bloating) | Multiple botanical ingredients | Anecdotal user reports | Mild | Take with food; discontinue if persistent |
| Acne flare-ups / skin reactions | Biotin, saw palmetto | Anecdotal; causal link unconfirmed | Mild to moderate | Consult GP if persistent; consider discontinuing supplement |
| Blood test interference (thyroid, troponin, hormones) | High-dose biotin | MHRA guidance issued; established risk | Clinically significant | Inform GP or laboratory before any blood tests; pause biotin as advised |
| Liver injury (hepatotoxicity) | Ashwagandha (Withania somnifera) | Case reports and case series | Serious / rare | Stop immediately if jaundice, dark urine, or abdominal pain; seek urgent medical attention |
| Allergic reaction | Marine collagen (fish/shellfish-derived) | Theoretical; based on known allergen profile | Potentially serious | Check full ingredient list; avoid if fish or shellfish allergy; consult GP or allergy specialist |
| Menstrual cycle changes | Phytoestrogenic and adaptogenic botanicals | Theoretical; not confirmed by clinical evidence | Uncertain | Consult GP, especially if hormone-sensitive condition present |
Known Side Effects and Reported Reactions
No clinical evidence confirms Nutrafol directly causes hair loss, but reported reactions include gastrointestinal upset, biotin interference with blood tests, and rare ashwagandha-associated liver injury.
Because Nutrafol is a food supplement rather than a licensed medicine, it has not been subject to the same formal clinical safety evaluation as pharmaceutical products. However, suspected adverse reactions to food supplements and herbal products can — and should — be reported via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk), which accepts reports from both patients and healthcare professionals. This helps build the UK's safety evidence base for supplements.
Experiencing these side effects? Our pharmacists can help you navigate them →
The following reactions have been reported anecdotally by users or noted in limited published data; they are not established adverse effects in the clinical sense:
-
Gastrointestinal discomfort, such as nausea, bloating, or stomach upset, particularly when taken on an empty stomach
-
Headaches and mild dizziness in some users
-
Skin reactions, including acne flare-ups, which some users have attributed to the high biotin content or hormonal-modulating botanicals such as saw palmetto — though a direct causal link has not been established
-
Changes in menstrual cycle in some women, potentially related to adaptogenic and phytoestrogenic ingredients; this association is theoretical and not confirmed by clinical evidence
Biotin and laboratory test interference: High-dose biotin, commonly present in hair supplements, can interfere with a range of immunoassay-based blood tests — including thyroid function tests, cardiac troponin assays, and other hormone tests — potentially producing falsely elevated or falsely low results. The MHRA has issued guidance on this risk. If you are due to have any blood tests, inform your GP, specialist, or the laboratory that you are taking a high-dose biotin supplement; they may advise you to pause it for a period before testing. Follow local laboratory or clinician advice on timing.
Ashwagandha and liver safety: Case reports and case series have described rare instances of liver injury (hepatotoxicity) associated with ashwagandha-containing supplements. If you develop symptoms such as jaundice (yellowing of the skin or eyes), dark urine, pale stools, severe abdominal pain, or persistent itching whilst taking Nutrafol, stop the supplement immediately and seek urgent medical attention.
Marine collagen and allergy risk: Nutrafol products containing marine collagen are typically derived from fish or shellfish. Individuals with known fish or shellfish allergies should check the full ingredient list carefully before use and seek advice from their GP or an allergy specialist.
Regarding the central question — can Nutrafol cause hair loss? — there is no established clinical evidence that Nutrafol directly causes hair loss. Some users have anecdotally reported increased shedding in the early weeks of use, sometimes described as a "shedding phase." This is speculative for supplements and is not a proven phenomenon in this context. If shedding occurs, it should not be assumed to be a normal or expected response; other causes should be considered, and you should seek medical review if shedding persists or worsens.
Who Should Use Nutrafol With Caution?
Pregnant women, those with hormone-sensitive conditions, people on anticoagulants or thyroid medications, and anyone with liver disease or fish allergies should seek GP advice before using Nutrafol.
Whilst Nutrafol is available without a prescription, certain groups of people should exercise particular caution or avoid it altogether without first seeking medical advice.
Pregnant and breastfeeding women should avoid Nutrafol. Several of its botanical ingredients — including ashwagandha and saw palmetto — have not been established as safe during pregnancy or lactation. The NHS and MHRA advise caution with herbal and botanical supplements during these periods due to insufficient safety data.
People with hormone-sensitive conditions, such as oestrogen receptor-positive breast cancer, endometriosis, uterine fibroids, or polycystic ovary syndrome (PCOS), should consult their GP or specialist before use. Some Nutrafol formulations contain phytoestrogenic compounds and adaptogens that may theoretically influence hormonal pathways, though direct clinical evidence of harm in these populations is currently lacking. The interaction risk should be considered theoretical and uncertain rather than established.
Individuals taking prescription medications should seek advice from their GP or pharmacist before starting Nutrafol. Potential interactions include:
-
Anticoagulants (e.g., warfarin) — some botanical ingredients may theoretically affect clotting pathways; this interaction is not well characterised and should be discussed with a clinician
-
Thyroid medications — high biotin levels can interfere with thyroid hormone assays, which may affect dose monitoring
-
Hormonal therapies, including the combined oral contraceptive pill or hormone replacement therapy (HRT) — due to the supplement's phytoestrogenic and anti-androgenic components; the clinical significance of this interaction is uncertain
People with pre-existing liver disease should exercise particular caution given the potential for ashwagandha-associated hepatotoxicity (see above). Discuss use with your GP or hepatologist before starting.
People with known allergies to any of the listed botanical ingredients, or to fish or shellfish (relevant to marine collagen-containing formulations), should review the full ingredient list carefully and seek medical advice.
People with autoimmune conditions should be cautious with immune-modulating adaptogens such as ashwagandha; the evidence base for this caution is limited but the theoretical risk warrants discussion with a clinician.
Children and adolescents should not use Nutrafol, as it has not been studied in these age groups and there are no safety or efficacy data to support its use in under-18s.
Always read the product label carefully and consult a healthcare professional if you are unsure whether a supplement is appropriate for your circumstances.
When to Seek Medical Advice About Hair Loss
Consult your GP if hair loss is sudden, patchy, accompanied by systemic symptoms, or involves scalp changes such as redness or scarring, as these may indicate conditions requiring urgent treatment.
Hair loss is a common concern affecting both men and women, but it can sometimes signal an underlying medical condition that requires proper investigation and treatment. Whilst supplements like Nutrafol may appeal as a convenient first step, it is important to recognise when professional medical assessment is necessary.
You should consult your GP if you experience:
-
Sudden or rapid hair loss, particularly if it occurs in patches (which may indicate alopecia areata)
-
Diffuse shedding that has persisted for more than two to three months
-
Hair loss accompanied by other symptoms, such as fatigue, weight changes, cold intolerance, or irregular periods — these may suggest thyroid dysfunction, iron deficiency anaemia, or other systemic conditions
-
Scalp changes, including redness, scaling, pain, burning, loss of visible follicular openings, inflammatory scale, or pustules — these features may indicate a scarring (cicatricial) alopecia, which requires urgent referral to a dermatologist, as early treatment is important to prevent permanent hair loss
-
Hair loss following a significant life event, such as childbirth, major surgery, or severe illness — this pattern is consistent with telogen effluvium and benefits from clinical confirmation
Your GP can arrange relevant investigations based on your clinical presentation. Routine blood tests may include a full blood count and ferritin level; thyroid function tests and hormonal profiles (such as androgen levels) are not routinely indicated and should be guided by clinical features — for example, androgen testing is more appropriate where there are signs of hyperandrogenism such as irregular periods, hirsutism, or acne. NICE CKS and Primary Care Dermatology Society (PCDS) guidance supports a structured, symptom-directed approach to diagnosing hair loss.
In many cases, referral to a consultant dermatologist is appropriate, particularly for suspected scarring alopecia, diagnostic uncertainty, or where first-line treatments have not been effective. If you choose to consult a trichologist, prioritise those with recognised professional accreditation and ensure they liaise with your GP or a medical specialist as needed, since trichology is not a statutorily regulated profession in the UK.
Self-treating with supplements before obtaining a diagnosis may delay appropriate management. If you are already using Nutrafol and notice increased shedding or worsening hair loss, discontinue use and seek medical advice. Please also consider reporting any suspected adverse reactions to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk), as this supports the UK's safety monitoring of supplements.
Evidence-Based Alternatives Available in the UK
Topical minoxidil and finasteride (for men) are the most evidence-based UK-available treatments for pattern hair loss, both supported by NICE and PCDS guidance and subject to regulatory oversight.
For those seeking hair loss treatments with a stronger evidence base and regulatory oversight, several options are available in the UK through the NHS or via licensed private prescribers.
Minoxidil (topical) is the most widely used topical treatment for androgenetic alopecia (pattern hair loss) in both men and women. Available over the counter in 2% and 5% formulations (see the EMC SmPC for Regaine for full prescribing information), it is thought to work primarily via ATP-sensitive potassium channel opening and vasodilation, prolonging the anagen (growth) phase of the hair cycle. It is supported by robust clinical trial data and is included in NICE CKS and PCDS guidance on pattern hair loss.
Oral minoxidil at low doses is available via private prescription in the UK; however, it does not currently hold a UK marketing authorisation for hair loss and is therefore used off-label. It carries additional adverse effects compared with the topical formulation, including hypertrichosis (unwanted hair growth elsewhere), fluid retention, oedema, and tachycardia. It should only be initiated and monitored by a clinician experienced in its use.
Finasteride (1 mg daily, licensed as Propecia) is an oral treatment for male pattern baldness in the UK. It works by inhibiting the enzyme 5-alpha reductase, thereby reducing dihydrotestosterone (DHT) levels — a key driver of follicular miniaturisation. It is available on private prescription and has a well-established evidence base (see the EMC SmPC for Propecia). Important safety information: the MHRA has issued warnings regarding finasteride and the risk of persistent sexual dysfunction (including after stopping the medicine) and psychiatric effects, including depression. Patients should be provided with the finasteride Patient Alert Card and should discuss these risks fully with their prescriber before starting treatment.
For nutritional deficiencies contributing to hair loss, targeted supplementation guided by blood test results — such as iron, vitamin D, or zinc — is a more evidence-informed approach than broad-spectrum hair supplements. The NHS recommends addressing deficiencies through diet where possible, with supplementation reserved for confirmed deficiencies.
Spironolactone is used off-label under specialist supervision for female pattern hair loss and hyperandrogenism-related hair thinning in women. It is not suitable for use in men or in women who may become pregnant, and requires specialist assessment.
Platelet-rich plasma (PRP) therapy and low-level laser therapy (LLLT) are emerging options available privately in the UK. The evidence base for both is still evolving and neither is routinely commissioned by the NHS. A consultation with a consultant dermatologist can help identify the most appropriate, evidence-based treatment pathway for your specific type and cause of hair loss.
Frequently Asked Questions
Can Nutrafol cause hair loss or increased shedding?
There is no established clinical evidence that Nutrafol directly causes hair loss. Some users have anecdotally reported increased shedding in the early weeks of use, but this is not a proven or expected response; if shedding persists or worsens, you should stop the supplement and seek medical advice.
Is Nutrafol safe to take with prescription medications in the UK?
Nutrafol may interact with certain prescription medicines, including anticoagulants such as warfarin, thyroid medications, and hormonal therapies. Always consult your GP or pharmacist before starting Nutrafol if you are taking any prescribed medicines.
What are the evidence-based alternatives to Nutrafol for hair loss available in the UK?
Topical minoxidil is available over the counter for both men and women with pattern hair loss, whilst finasteride is available on private prescription for men. Both are supported by robust clinical evidence and are referenced in NICE and PCDS guidance, unlike food supplements such as Nutrafol.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
